Novoray Past Earnings Performance
Past criteria checks 4/6
Novoray has been growing earnings at an average annual rate of 19.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 19.1% per year. Novoray's return on equity is 16.2%, and it has net margins of 26.2%.
Key information
19.4%
Earnings growth rate
16.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 19.1% |
| Return on equity | 16.2% |
| Net Margin | 26.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Is Now The Time To Put Novoray (SHSE:688300) On Your Watchlist?
Nov 29
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher
Oct 18These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely
Oct 16What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?
Sep 26If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity
Aug 20Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business
Jul 29What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You
Jul 13Why Novoray Corporation (SHSE:688300) Could Be Worth Watching
Jun 19If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity
May 13Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?
Apr 23Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 01Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts
Mar 28Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%
Mar 01When Should You Buy Novoray Corporation (SHSE:688300)?
Feb 27Revenue & Expenses Breakdown
How Novoray makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 895 | 234 | 66 | 56 |
| 30 Jun 24 | 841 | 218 | 65 | 55 |
| 31 Mar 24 | 769 | 197 | 61 | 51 |
| 31 Dec 23 | 712 | 174 | 59 | 47 |
| 30 Sep 23 | 685 | 182 | 60 | 45 |
| 30 Jun 23 | 625 | 169 | 57 | 39 |
| 31 Mar 23 | 630 | 174 | 55 | 38 |
| 31 Dec 22 | 662 | 188 | 51 | 38 |
| 30 Sep 22 | 657 | 175 | 47 | 38 |
| 30 Jun 22 | 686 | 186 | 45 | 40 |
| 31 Mar 22 | 663 | 179 | 46 | 38 |
| 31 Dec 21 | 625 | 173 | 46 | 35 |
| 30 Sep 21 | 581 | 169 | 49 | 30 |
| 30 Jun 21 | 522 | 147 | 49 | 26 |
| 31 Mar 21 | 473 | 130 | 44 | 24 |
| 31 Dec 20 | 404 | 111 | 44 | 20 |
| 30 Sep 20 | 367 | 92 | 46 | 19 |
| 30 Jun 20 | 341 | 82 | 45 | 16 |
| 31 Mar 20 | 321 | 78 | 50 | 13 |
| 31 Dec 19 | 315 | 75 | 48 | 13 |
| 30 Sep 19 | 298 | 69 | 43 | 12 |
| 30 Jun 19 | 292 | 67 | 41 | 12 |
| 31 Mar 19 | 277 | 60 | 38 | 11 |
| 31 Dec 18 | 278 | 58 | 38 | 11 |
| 30 Sep 18 | 264 | 54 | 37 | 10 |
| 30 Jun 18 | 249 | 50 | 37 | 10 |
| 31 Mar 18 | 230 | 46 | 34 | 9 |
| 31 Dec 17 | 211 | 42 | 32 | 8 |
| 30 Sep 17 | 193 | 41 | 31 | 6 |
| 30 Jun 17 | 176 | 39 | 31 | 3 |
| 31 Mar 17 | 165 | 36 | 32 | 2 |
| 31 Dec 16 | 154 | 33 | 33 | 0 |
| 30 Sep 16 | 143 | 27 | 32 | 0 |
| 30 Jun 16 | 132 | 20 | 31 | 0 |
| 31 Mar 16 | 127 | 19 | 30 | 0 |
| 31 Dec 15 | 122 | 18 | 30 | 0 |
| 30 Sep 15 | 121 | 19 | 29 | 0 |
| 30 Jun 15 | 132 | 20 | 29 | 0 |
| 31 Mar 15 | 131 | 19 | 30 | 0 |
| 31 Dec 14 | 125 | 19 | 30 | 0 |
| 31 Dec 13 | 120 | 14 | 30 | 0 |
Quality Earnings: 688300 has high quality earnings.
Growing Profit Margin: 688300's current net profit margins (26.2%) are lower than last year (26.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688300's earnings have grown by 19.4% per year over the past 5 years.
Accelerating Growth: 688300's earnings growth over the past year (28.7%) exceeds its 5-year average (19.4% per year).
Earnings vs Industry: 688300 earnings growth over the past year (28.7%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 688300's Return on Equity (16.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 02:04 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Novoray Corporation is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zheng Zhou | China Merchants Securities Co. Ltd. |
| Chao Li | Citic Securities Co., Ltd. |
| Zhaohua Wang | Everbright Securities Co. Ltd. |